FDA Inspection 1208651 — Sarah Jackson, M.D.
The FDA completed an inspection of Sarah Jackson, M.D. on June 15, 2023 in New Orleans, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 15, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- New Orleans, LA (United States)
Additional Details
Clinical Investigator (CI)